Lung Kee (Bermuda) Holdings Limited

HKSE 0255.HK

Lung Kee (Bermuda) Holdings Limited EBITDA Margin for the year ending December 31, 2023: 3.92%

Lung Kee (Bermuda) Holdings Limited EBITDA Margin is 3.92% for the year ending December 31, 2023, a -65.23% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Lung Kee (Bermuda) Holdings Limited EBITDA Margin for the year ending December 31, 2022 was 11.29%, a -45.65% change year over year.
  • Lung Kee (Bermuda) Holdings Limited EBITDA Margin for the year ending December 31, 2021 was 20.76%, a 16.71% change year over year.
  • Lung Kee (Bermuda) Holdings Limited EBITDA Margin for the year ending December 31, 2020 was 17.79%, a 10.70% change year over year.
  • Lung Kee (Bermuda) Holdings Limited EBITDA Margin for the year ending December 31, 2019 was 16.07%, a 5.80% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
SV Wall Street
HKSE: 0255.HK

Lung Kee (Bermuda) Holdings Limited

CEO Mr. Tit Lung Siu
IPO Date March 5, 1993
Location Hong Kong
Headquarters Unit A, Kings Wing Plaza 2
Employees 3,000
Sector Materials
Industries
Plastics Bread & Bakery Cleaning Supplies Composite Materials Containers & Packaging Glass Personal Care Tobacco
Description

Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee (Bermuda) Holdings Limited is a subsidiary of Pan Island Investments Limited.

Similar companies

0259.HK

Yeebo (International Holdings) Limited

USD 0.50

-0.52%

StockViz Staff

February 8, 2025

Any question? Send us an email